A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of
Investigational Therapeutics for Hospitalized Patients with COVID-19
This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either a study drug plus current standard of care (SOC), or with placebo plus current SOC.
Principal Investigator: Dr. Kaharu Sumino
This study was funded by the Foundation through the National Institute of Allergy and Infectious Diseases (NIAID),
National Institutes of Health (NIH) and carried out by the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT).
Investigational Therapeutics for Hospitalized Patients with COVID-19
This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either a study drug plus current standard of care (SOC), or with placebo plus current SOC.
Principal Investigator: Dr. Kaharu Sumino
This study was funded by the Foundation through the National Institute of Allergy and Infectious Diseases (NIAID),
National Institutes of Health (NIH) and carried out by the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT).